Status:

TERMINATED

Treatment of Post-Operative Sinonasal Polyposis With Topical Furosemide

Lead Sponsor:

Thomas Jefferson University

Conditions:

Nasal Polyps

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Prior studies have suggested that topical furosemide may reduce the recurrence of sinonasal polyposis following sinus surgery. This project aims to further investigate that claim through a blinded ran...

Eligibility Criteria

Inclusion

  • Patients with chronic rhinosinusitis and sinonasal polyposis who are candidates for functional endoscopic sinus surgery

Exclusion

  • Hypersensitivity to furosemide or sulfonamides
  • pregnancy
  • history of tinnitus
  • history of sensorineural hearing loss
  • poorly controlled diabetes
  • current diuretic therapy
  • known electrolyte disorder
  • currently taking aminoglycosides
  • BUN and creatinine levels out of the normal range
  • history of renal disease
  • allergy to sulfonamides

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 14 2022

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT03362515

Start Date

December 1 2017

End Date

April 14 2022

Last Update

August 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomas Jefferson University Department of Otolaryngology

Philadelphia, Pennsylvania, United States, 19107